Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDKN2B Antikörper

CDKN2B Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7182212
  • Target Alle CDKN2B Antikörper anzeigen
    CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
    Reaktivität
    • 61
    • 17
    • 16
    • 5
    • 2
    • 2
    • 2
    • 2
    • 1
    Human
    Wirt
    • 50
    • 11
    • 1
    Kaninchen
    Klonalität
    • 52
    • 10
    Polyklonal
    Konjugat
    • 34
    • 6
    • 5
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CDKN2B Antikörper ist unkonjugiert
    Applikation
    • 49
    • 34
    • 29
    • 28
    • 18
    • 15
    • 6
    • 5
    • 2
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
    Kreuzreaktivität
    Human, Maus, Ratte
    Aufreinigung
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
    Immunogen
    Synthesized peptide derived from Human p15 INK antibody.
    Isotyp
    IgG
    Top Product
    Discover our top product CDKN2B Primärantikörper
  • Applikationshinweise
    WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
    Andere Bezeichnung
    CDKN2B (CDKN2B Produkte)
    Hintergrund

    Background: Interacts strongly with CDK4 and CDK6. Potent inhibitor. Potential effector of TGF-beta induced cell cycle arrest.

    Nynke Y. Rots, Blood, Apr 1999, 93: 2721 - 2729.
    Stefan Faderl, Clin. Cancer Res., Jul 1999, 5: 1855.
    George Wu, Mol. Biol. Cell, Mar 2007, 18: 1018 - 1029.
    A. Koenig, Vet. Pathol., Jul 2002, 39: 458.

    Aliases: CDK inhibitory protein antibody, CDK4B Inhibitor antibody, Cdkn2b antibody, CDN2B_HUMAN antibody, Cyclin dependent kinase 4 inhibitor B antibody, Cyclin Dependent Kinase Inhibitor 2B antibody, Cyclin dependent kinase inhibitor 2B p15 inhibits CDK4 antibody, Cyclin dependent kinases 4 and 6 binding protein antibody, Cyclin-dependent kinase 4 inhibitor B antibody, INK4B antibody, MTS 2 antibody, MTS-2 antibody, MTS2 antibody, Multiple tumor suppressor 2 antibody, Multiple Tumor Supressor 2 antibody, OTTHUMP00000021154 antibody, OTTHUMP00000021155 antibody, p14 CDK inhibitor antibody, p14 INK4b antibody, p14-INK4b antibody, P15 antibody, p15 CDK inhibitor antibody, p15 inhibits CDK4 antibody, p15 INK4b antibody, p15-INK4b antibody, p15INK4B antibody, TP 15 antibody, TP15 antibody

    UniProt
    P42772
    Pathways
    Zellzyklus, Mitotic G1-G1/S Phases
Sie sind hier:
Kundenservice